HealthQuill RSV Season
The Food and Drug Administration has approved Merck & Co. Inc.’s jab for preventing respiratory syncytial virus (RSV) in infants up to one year of age for the first RSV season.
Drugs Health Pharma

Merck & Co.’s RSV injection for infants gets nod from US drug regulator

HQ Team June 10, 2025: The Food and Drug Administration has approved Merck & Co. Inc.’s jab for preventing respiratory syncytial virus (RSV).

Read More
Pfizer Inc., a US pharmaceutical and biotechnology corporation, announced its single dose of respiratory syncytial virus (RSV) vaccine would maintain protection from the disease through to a second season.
Drugs Health Pharma

Pfizer says RSV vaccine can ensure protection into second season

HQ Team March 1, 2024: Pfizer Inc., a US pharmaceutical and biotechnology corporation, announced its single dose of respiratory syncytial virus (RSV) vaccine.

Read More